相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural basis for activation of CB1 by an endocannabinoid analog
Kaavya Krishna Kumar et al.
NATURE COMMUNICATIONS (2023)
Structural basis of selective cannabinoid CB2 receptor activation
Xiaoting Li et al.
NATURE COMMUNICATIONS (2023)
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
Xin Yang et al.
NATURE CHEMICAL BIOLOGY (2022)
A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1
Xiaoyan Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua et al.
CELL (2020)
Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex
Changrui Xing et al.
CELL (2020)
Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations
Beihong Ji et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Molecular switches in GPCRs
Slawomir Filipek
CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
Mikkel Soes Ibsen et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
William T. Booth et al.
MOLECULES (2019)
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE CHEMICAL BIOLOGY (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor
Alessandra Porcu et al.
NEUROPHARMACOLOGY (2018)
Cryo-EM structure of human rhodopsin bound to an inhibitory G protein
Yanyong Kang et al.
NATURE (2018)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation
Marialessandra Contino et al.
FRONTIERS IN NEUROSCIENCE (2017)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
David M. Thal et al.
NATURE (2016)
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
Charles W. Schindler et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1
Jill E. Chrencik et al.
CELL (2015)
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
Wilfrid Mazier et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Monique Vallee et al.
SCIENCE (2014)
Cannabinoid signaling and liver therapeutics
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2013)
Structure of the agonist-bound neurotensin receptor
Jim F. White et al.
NATURE (2012)
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2012)
Crystal Structure of a Lipid G Protein-Coupled Receptor
Michael A. Hanson et al.
SCIENCE (2012)
Cannabinoid CB1 receptor ligand binding and function examined through mutagenesis studies of F200 and S383
Doree F. Sitkoff et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β2AR
Dorota Latek et al.
JOURNAL OF MOLECULAR MODELING (2011)
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
Mark D. Black et al.
PSYCHOPHARMACOLOGY (2011)
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
Dow P. Hurst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Transmembrane Helical Domain of the Cannabinoid CB1 Receptor
Joong-Youn Shim
BIOPHYSICAL JOURNAL (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists
C. A. Lunn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Lipid-mediated dimerization of β2-adrenergic receptor reveals important clues for cannabinoid receptors
E. Dainese et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation
Ying Pei et al.
CHEMISTRY & BIOLOGY (2008)
CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a
Jason L. Niehaus et al.
MOLECULAR PHARMACOLOGY (2007)
GPCR structure-based virtual screening approach for CB2 antagonist search
Jian-Zhong Chen et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer
Diane L. Lynch et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction
JY Shim et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis
T Tuccinardi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
(-)-7′-isothiocyanato-11-hydroxy-1′,1-′dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor
RP Picone et al.
MOLECULAR PHARMACOLOGY (2005)
Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor
OMH Salo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study
C Montero et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
The endogenous cannabinoid system and its role in nociceptive behavior
BF Cravatt et al.
JOURNAL OF NEUROBIOLOGY (2004)
Development of a 3D model for the human cannabinoid CB1 receptor
OMH Salo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction
JY Shim et al.
BIOPOLYMERS (2003)
3D structural model of the G-protein-coupled cannabinoid CB2 receptor
XQ Xie et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Cannabinoids and multiple sclerosis
RG Pertwee
PHARMACOLOGY & THERAPEUTICS (2002)
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor
P Gouldson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
